Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04106219
Title A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: child | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | BEL | AUS


No variant requirements are available.